The production of Atorvastatin API is a massive global operation. As of 2026, India and China are the dominant players, producing over 50% of the world's supply due to their advanced chemical infrastructure and cost-effective manufacturing.

Leading global companies involved in the production of this API include Teva Pharmaceutical Industries, Sun Pharmaceutical, Dr. Reddy’s Laboratories, and Centrient Pharmaceuticals. These companies supply the raw material to thousands of other pharmaceutical firms worldwide, ensuring that affordable cholesterol medication is available in almost every country.